Jim Simons Chimerix Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Chimerix Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,339,290 shares of CMRX stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,339,290

Previous 1,483,178 9.7%

Holding current value

$1.18 Million

Previous $1.31 Million 4.6%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.77 - $1.07 $110,793 - $153,960	-143,888 Reduced 9.7%	1,339,290 $1.25 Million
Q2 2024 Aug 09, 2024	SELL	$0.87 - $1.05 $322,454 - $389,168	-370,637 Reduced 19.99%	1,483,178 $1.31 Million
Q1 2024 May 13, 2024	BUY	$0.91 - $1.26 $265,543 - $367,675	291,806 Added 18.68%	1,853,815 $1.97 Million
Q4 2023 Feb 13, 2024	BUY	$0.9 - $1.06 $468,810 - $552,154	520,900 Added 50.03%	1,562,009 $1.5 Million
Q3 2023 Nov 14, 2023	SELL	$0.94 - $1.23 $968,388 - $1.27 Million	-1,030,200 Reduced 49.74%	1,041,109 $999,000
Q2 2023 Aug 11, 2023	BUY	$1.1 - $1.54 $776,091 - $1.09 Million	705,538 Added 51.66%	2,071,309 $2.51 Million
Q1 2023 May 12, 2023	BUY	$1.19 - $2.09 $843,681 - $1.48 Million	708,976 Added 107.94%	1,365,771 $1.72 Million
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.35 $323,455 - $455,162	193,686 Added 41.82%	656,795 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $1.04 Million - $1.58 Million	-573,840 Reduced 55.34%	463,109 $894,000
Q2 2022 Aug 12, 2022	SELL	$1.34 - $5.34 $563,925 - $2.25 Million	-420,840 Reduced 28.87%	1,036,949 $2.16 Million
Q1 2022 May 13, 2022	SELL	$4.58 - $6.8 $697,479 - $1.04 Million	-152,288 Reduced 9.46%	1,457,789 $6.68 Million
Q4 2021 Feb 11, 2022	SELL	$5.23 - $7.18 $3.26 Million - $4.47 Million	-622,805 Reduced 27.89%	1,610,077 $10.4 Million
Q3 2021 Nov 12, 2021	SELL	$5.94 - $8.75 $1.58 Million - $2.33 Million	-266,767 Reduced 10.67%	2,232,882 $13.8 Million
Q2 2021 Aug 13, 2021	SELL	$7.54 - $9.79 $2.56 Million - $3.32 Million	-338,900 Reduced 11.94%	2,499,649 $20 Million
Q1 2021 May 13, 2021	SELL	$4.76 - $11.25 $466,480 - $1.1 Million	-98,000 Reduced 3.34%	2,838,549 $27.4 Million
Q4 2020 Feb 10, 2021	SELL	$2.43 - $5.42 $22,453 - $50,080	-9,240 Reduced 0.31%	2,936,549 $14.2 Million
Q3 2020 Nov 13, 2020	SELL	$2.3 - $3.72 $28,749 - $46,500	-12,500 Reduced 0.42%	2,945,789 $7.34 Million
Q2 2020 Aug 13, 2020	SELL	$1.33 - $3.63 $387,992 - $1.06 Million	-291,724 Reduced 8.98%	2,958,289 $9.17 Million
Q1 2020 May 14, 2020	BUY	$1.27 - $2.33 $375,763 - $689,393	295,877 Added 10.02%	3,250,013 $4.68 Million
Q4 2019 Feb 13, 2020	BUY	$1.3 - $2.72 $850,861 - $1.78 Million	654,509 Added 28.46%	2,954,136 $6 Million
Q3 2019 Nov 13, 2019	BUY	$1.93 - $4.21 $1.04 Million - $2.27 Million	539,458 Added 30.65%	2,299,627 $5.4 Million
Q2 2019 Aug 12, 2019	BUY	$2.05 - $4.32 $892,528 - $1.88 Million	435,380 Added 32.86%	1,760,169 $7.6 Million
Q1 2019 May 14, 2019	BUY	$1.79 - $3.12 $1.36 Million - $2.38 Million	762,515 Added 135.61%	1,324,789 $2.78 Million
Q4 2018 Feb 13, 2019	BUY	$2.24 - $3.9 $1.26 Million - $2.19 Million	562,274 New	562,274 $1.45 Million

Others Institutions Holding CMRX

# of Institutions

Shares Held

37M

Call Options Held

52.7K

Put Options Held

130K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account